UC Investments
Overview
Investment management for the University of California's portfolio.
Deals · 12mo
4
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Qolab | Jul 2026Led | $54 MSeries B | |
Qubic | Jun 2026Participated | $2 MSeed | |
Prenosis | Feb 2026Participated | $20 MSeries A | |
LM Arena | Jan 2026Led | $150 MSeries A | |
LM Arena | May 2025Led | $100 MSeed | |
Eikon Therapeutics | Feb 2025Led | $351 MSeries D | |
Digestiva | Jul 2024Participated | $18 MSeries A | |
TORL BioTherapeutics | Apr 2024Participated | $158 MSeries B | |
Neurona Therapeutics | Feb 2024Participated | $120 MOther Equity | |
Abridge | Oct 2023Participated | $30 MSeries B | |
Eikon Therapeutics | Jan 2022Participated | $518 MSeries B | |
Databricks | Aug 2021Participated | $1.6 BSeries H | |
Qolab | Jul 2026Led | $54 MSeries B | |
Qubic | Jun 2026Participated | $2 MSeed | |
Prenosis | Feb 2026Participated | $20 MSeries A | |
LM Arena | Jan 2026Led | $150 MSeries A | |
LM Arena | May 2025Led | $100 MSeed | |
Eikon Therapeutics | Feb 2025Led | $351 MSeries D | |
Digestiva | Jul 2024Participated | $18 MSeries A | |
TORL BioTherapeutics | Apr 2024Participated | $158 MSeries B | |
Neurona Therapeutics | Feb 2024Participated | $120 MOther Equity | |
Abridge | Oct 2023Participated | $30 MSeries B | |
Eikon Therapeutics | Jan 2022Participated | $518 MSeries B | |
Databricks | Aug 2021Participated | $1.6 BSeries H |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 1 | 1 |
| Series A | 1 | 2 |
| Series B | 1 | 4 |
| Series C+ | 1 | 1 |
| Other Equity | 0 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jun '20 | 1 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 1 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 1 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 1 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 1 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 1 |
| Mar '24 | 0 |
| Apr '24 | 1 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 1 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 1 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 1 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 1 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 1 |
| Jul '26 | 1 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 8 |
| Enterprise Software | 5 |
| AI & Machine Learning | 5 |
| Data, Analytics & IT | 4 |
| Space & Frontier Tech | 2 |
| Developer Tools | 2 |
| Hardware & Robotics | 1 |
| Media & Entertainment | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 0 |
| $10M-$25M | 2 |
| $25M-$50M | 1 |
| $50M-$100M | 2 |
| $100M-$250M | 5 |
| $250M-$500M | 1 |
| $500M-$1B | 1 |
| $1B+ | 1 |
Deals By Geography
Top 3 of 3 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 12 |
| 90028 | 1 |
| Canada | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| The Column Group | 4 |
| Andreessen Horowitz | 3 |
| T. Rowe Price Associates | 3 |
| Alexandria Venture Investments | 2 |
| AME Cloud Ventures | 2 |
| Canada Pension Plan Investment Board | 2 |
| E15 VC | 2 |
| Euclidean Capital | 2 |
| Felicis Ventures | 2 |
| Foresite Capital | 2 |
| General Catalyst | 2 |
| Hartford HealthCare Endowment | 2 |
| Kleiner Perkins | 2 |
| Lightspeed Venture Partners | 2 |
| Lux Capital | 2 |
| Schroders Capital | 2 |
| Soros Capital | 2 |
| StepStone Group | 2 |
| The House Fund | 2 |
| Alta Park Capital | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 4 | 29% |
| Participating | 10 | 71% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 25% |
| Co-led | 3 | 75% |